Find Out if the Oncotype DX Test Can Help Personalize Your Treatment

The Oncotype DX tests are genomic tests that may help guide treatment decisions for patients with early-stage breast cancer: non-invasive breast cancer, often referred to as ductal carcinoma in situ (DCIS), and help early-stage invasive breast cancer patients with estrogen receptor-positive (ER+) disease evaluate if they will benefit from chemotherapy.

Please take the quick quiz below to help you determine whether the Oncotype DX test may be appropriate for you:


  • Are you a newly diagnosed breast cancer patient or caregiver trying to determine what treatment plan is right for you or a loved one?

  • What stage is your breast cancer?

    I'm not sure. How do I find out what stage my breast cancer is?

    Breast Cancer Stages

    Cancer staging is the assessment of how far a person's breast cancer has progressed and influences treatment decisions and prognosis. Breast cancer staging is a classification method based on the size of your cancer and how far it has (or hasn’t) spread beyond its original location within the breast. It is usually determined after your tumor is removed and your lymph nodes have been examined, although additional blood and imaging tests may also be needed. Your medical team can provide you with a copy of your pathology report.

    Read more or call us 855.5000.ASK (855-500-0275).
  • Has your breast cancer been diagnosed as estrogen receptor positive (ER+)?

    I'm not sure. How do I find out if my cancer is estrogen receptor-positive?

    Estrogen Receptor Status

    Hormones are naturally occurring chemicals in the body that stimulate the growth of hormone-sensitive tissues, such as those in the breast. In some cases of breast cancer, the hormones estrogen and progesterone may stimulate tumor growth. Your doctor will likely have your tumor tested to find out if your cancer is hormone-dependent.

    Your hormone receptor status in the cancer is important in determining the appropriate treatment options for your breast cancer. If you do not know your hormone receptor status, please check with your physician.

    Read more or call us 855.5000.ASK (855-500-0275).
  • Has your breast cancer been diagnosed as human epidermal growth factor receptor-positive (HER2+)?

    I’m not sure. How do I find out if my cancer is Human Epidermal Growth Factor Receptor 2 (HER2)-positive?

    Human Epidermal Growth Factor Receptor 2 (HER2) Status

    A protein that appears in the cancer cells of some women with breast cancer. A woman whose tumor has greater than normal levels of HER2 is considered HER2 positive. A woman whose tumor has normal levels of HER2 is considered HER2 negative. Cancer cells that have high levels of HER2 tend to grow quickly and respond well to anti-HER2 therapy.

    Your Human Epidermal Growth Factor Receptor 2 (HER2) status is important in determining the appropriate treatment options for your breast cancer. If you do not know your hormone receptor status, please check with your physician.

    Read more or call us 855.5000.ASK (855-500-0275).
  • Does your breast cancer have lymph node involvement?

    I’m not sure. How do I find out I have lymph node involvement?

    Lymph Node Involvement

    If a woman diagnosed with breast cancer has lymph node involvement, it means that her cancer has spread from her original breast tumor to the underarm lymph nodes on the side of her breast cancer. Lymph node status is determined when your doctor removes one or several of your lymph nodes so they can be examined under a microscope for cancer cells.

    Read more or call us 855.5000.ASK (855-500-0275).